SCHEMBL31250899

SCHEMBL31250899

CCOC(=O)c1cnc2cc(Cl)nn2c1C1CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.49
▸ RAB9A P51151 4/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ TP53 P04637 3/20 0.47
▸ RXFP1 Q9HBX9 2/20 0.47
▸ KMT2A Q03164 5/20 0.46
▸ MEN1 O00255 4/20 0.46
▸ CSNK1D P48730 2/20 0.44
▸ GAA P10253 6/20 0.43
▸ KDM4E B2RXH2 6/20 0.43
▸ HPGD P15428 4/20 0.43
▸ CYP2C19 P33261 3/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ MALT1 Q9UDY8 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.42
▸ GLA P06280 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19492616 0.88 CYP1A2 (0.48) NPC1RAB9ASMN1; SMN2TP53RXFP1
SCHEMBL19492487 0.83 KDM4E (0.48) NPC1RAB9ASMN1; SMN2TP53RXFP1
SCHEMBL18805714 0.81 MALT1 (0.48) NPC1RAB9ASMN1; SMN2TP53KMT2A
SCHEMBL17293115 0.79 NPC1 (0.51) NPC1RAB9ASMN1; SMN2TP53RXFP1
SCHEMBL18787721 0.77 MALT1 (0.44) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL25375133 0.74 CSNK1D (0.49) NPC1RAB9ASMN1; SMN2TP53KMT2A
SCHEMBL239039 0.74 NPC1 (0.63) NPC1RAB9ASMN1; SMN2TP53RXFP1
SCHEMBL19464210 0.74 KDM4E (0.48) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL18787731 0.74 MALT1 (0.52) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL31208517 0.74 IGF1R (0.43) NPC1RAB9ASMN1; SMN2TP53KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720058-A2 BIFUNCTIONAL DEGRADERS AND USES THEREOF Casma Therapeutics, Inc. (US) 2026-04-08 — — EP disclosed
WO-2024249291-A2 BIFUNCTIONAL DEGRADERS AND USES THEREOF CASMA THERAPEUTICS, INC. (US) 2024-12-05 — — WO disclosed
Send feedback